全文获取类型
收费全文 | 1501篇 |
免费 | 156篇 |
国内免费 | 29篇 |
出版年
2021年 | 12篇 |
2020年 | 9篇 |
2018年 | 10篇 |
2017年 | 9篇 |
2016年 | 18篇 |
2015年 | 29篇 |
2014年 | 34篇 |
2013年 | 43篇 |
2012年 | 47篇 |
2011年 | 102篇 |
2010年 | 62篇 |
2009年 | 46篇 |
2008年 | 55篇 |
2007年 | 54篇 |
2006年 | 37篇 |
2005年 | 69篇 |
2004年 | 57篇 |
2003年 | 64篇 |
2002年 | 51篇 |
2001年 | 51篇 |
2000年 | 48篇 |
1999年 | 38篇 |
1998年 | 33篇 |
1997年 | 34篇 |
1996年 | 15篇 |
1995年 | 21篇 |
1994年 | 16篇 |
1993年 | 37篇 |
1992年 | 54篇 |
1991年 | 44篇 |
1990年 | 36篇 |
1989年 | 31篇 |
1988年 | 36篇 |
1987年 | 33篇 |
1986年 | 27篇 |
1985年 | 35篇 |
1984年 | 25篇 |
1983年 | 11篇 |
1982年 | 12篇 |
1980年 | 15篇 |
1979年 | 23篇 |
1978年 | 17篇 |
1977年 | 15篇 |
1976年 | 12篇 |
1975年 | 14篇 |
1974年 | 10篇 |
1972年 | 16篇 |
1971年 | 11篇 |
1968年 | 8篇 |
1967年 | 9篇 |
排序方式: 共有1686条查询结果,搜索用时 15 毫秒
1.
2.
I Verhamme J O Kvassman D Day S Debrock N Vleugels P J Declerck J D Shore 《The Journal of biological chemistry》1999,274(25):17511-17517
The serpin plasminogen activator inhibitor-1 (PAI-1) slowly converts to an inactive latent form by inserting a major part of its reactive center loop (RCL) into its beta-sheet A. A murine monoclonal antibody (MA-33B8), raised against the human plasminogen activator (tPA).PAI-1 complex, rapidly inactivates PAI-1. Results presented here indicate that MA-33B8 induces acceleration of the active-to-latent conversion. The antibody-induced inactivation of PAI-1 labeled with the fluorescent probe N, N'-dimethyl-N-(acetyl)-N'-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) ethylene diamine (NBD) at P9 in the RCL caused a fluorescence enhancement and shift identical to those accompanying the spontaneous conversion of the P9.NBD PAI-1 to the latent form. Like latent PAI-1, antibody-inactivated PAI-1 was protected from cleavage by elastase. The rate constants for MA-33B8 binding, measured by NBD fluorescence or inactivation, were similar (1.3-1.8 x 10(4) M-1 s-1), resulting in a 4000-fold faster inactivation at 4.2 microM antibody binding sites. The apparent antibody binding rate constant, at least 1000 times slower than one limited by diffusion, indicates that exposure of its epitope depends on an unfavorable equilibrium of PAI-1. Our observations are consistent with this idea and suggest that the equilibrium involves partial insertion of the RCL into sheet A: latent, RCL-cleaved, and tPA-complexed PAI-1, which are inactive loop-inserted forms, bound much faster than active PAI-1 to MA-33B8, whereas two loop-extracted forms of PAI-1, modified to prevent loop insertion, did not bind or bound much more weakly to the antibody. 相似文献
3.
Nathan D. Mathewson Orr Ashenberg Itay Tirosh Simon Gritsch Elizabeth M. Perez Sascha Marx Livnat Jerby-Arnon Rony Chanoch-Myers Toshiro Hara Alyssa R. Richman Yoshinaga Ito Jason Pyrdol Mirco Friedrich Kathrin Schumann Michael J. Poitras Prafulla C. Gokhale L. Nicolas Gonzalez Castro Marni E. Shore Kai W. Wucherpfennig 《Cell》2021,184(5):1281-1298.e26
4.
5.
6.
7.
8.
9.
10.
Intestinal synthesis of 24-keto-1,25-dihydroxyvitamin D3. A metabolite formed in vivo with high affinity for the vitamin D cytosolic receptor 总被引:1,自引:0,他引:1
J L Napoli B C Pramanik P M Royal T A Reinhardt R L Horst 《The Journal of biological chemistry》1983,258(15):9100-9107
24-Keto-1,25-dihydroxyvitamin D3 has been identified as an intestinal metabolite of 1,25-dihydroxyvitamin D3 by ultraviolet absorbance, mass spectroscopy, and chemical reactivity. The metabolite was produced from 1,25-dihydroxyvitamin D3 and 1,24R,25-trihydroxyvitamin D3 in rat intestinal mucosa homogenates. 24-Keto-1,25-dihydroxyvitamin D3 is present in vivo in the plasma and small intestinal mucosa of rats fed a stock diet, receiving no exogenous 1,25-dihydroxyvitamin D3, and in the plasma and small intestinal mucosa of rats dosed chronically with 1,25-dihydroxyvitamin D3. 24-Keto-1,25-dihydroxyvitamin D3 has affinity equivalent to 1,24R,25-trihydroxyvitamin D3 for the 3.7 S cytosolic receptor specific for 1,25-dihydroxyvitamin D3 in the intestine and thymus. In cytosolic preparations contaminated with the 5 S vitamin D-binding protein, both metabolites are about 7-fold less potent than 1,25-dihydroxyvitamin D3. In contrast, in cytosolic preparations largely free of the 5 S binding protein, both metabolites are equipotent with the parent compound. No evidence was obtained supporting a substantial presence of 23-keto-1,25-dihydroxyvitamin D3 in vivo; nor was the latter compound generated in detectable amounts from 1,25-dihydroxyvitamin D3 by intestinal homogenates. Thus, C-24 oxidation is a significant pathway of intestinal 1,25-dihydroxyvitamin D3 metabolism that produces metabolites with high affinity for the cytosolic receptor which mediates vitamin D action. 相似文献